TY  - GEN
AU  - Jacobson,J M
AU  - Spritzler,J
AU  - Fox,L
AU  - Fahey,J L
AU  - Jackson,J B
AU  - Chernoff,M
AU  - Wohl,D A
AU  - Wu,A W
AU  - Hooton,T M
AU  - Sha,B E
AU  - Shikuma,C M
AU  - MacPhail,L A
AU  - Simpson,D M
AU  - Trapnell,C B
AU  - Basgoz,N
TI  - Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group
SN  - 0022-1899
PY  - 1999///0729
KW  - Acquired Immunodeficiency Syndrome
KW  - complications
KW  - Adult
KW  - Antigens, CD
KW  - analysis
KW  - Double-Blind Method
KW  - Esophageal Diseases
KW  - Ethnicity
KW  - Female
KW  - HIV Infections
KW  - Humans
KW  - Male
KW  - Placebos
KW  - Quality of Life
KW  - Receptors, Tumor Necrosis Factor
KW  - Receptors, Tumor Necrosis Factor, Type II
KW  - Stomatitis, Aphthous
KW  - drug therapy
KW  - Thalidomide
KW  - adverse effects
KW  - Tumor Necrosis Factor-alpha
KW  - Ulcer
KW  - United States
N1  - Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1086/314834
ER  -